Pulse Biosciences (PLSE) Net Equity Issued and Repurchased (2016 - 2022)

Pulse Biosciences' Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at -$29000.0 for Q4 2022.

• In Q4 2022, Net Equity Issued and Repurchased changed N/A year-over-year to -$29000.0; the TTM figure through Dec 2023 stood at -$99000.0 (down 101.2% YoY), while the FY2022 annual figure was $14.9 million, down 73.78% from the prior year.
• Net Equity Issued and Repurchased for Q4 2022 stood at -$29000.0, up from -$70000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $29.5 million in Q2 2020, with the low at -$261000.0 in Q3 2020.
• The 4-year median for Net Equity Issued and Repurchased is $263500.0 (2019), against an average of $5.1 million.
• The sharpest annual moves came in 2021 and 2022: Net Equity Issued and Repurchased soared 3298.85% in 2021, then sank 100.84% in 2022.
• Pulse Biosciences' Net Equity Issued and Repurchased stood at $272000.0 in 2019, then slumped by 123.53% to -$64000.0 in 2020, then surged by 13145.31% to $8.3 million in 2021, then tumbled by 100.35% to -$29000.0 in 2022.
• Business Quant data shows PLSE's Net Equity Issued and Repurchased at -$29000.0 in Q4 2022, -$70000.0 in Q3 2022, and $8.3 million in Q3 2021.